Listing External IP Records

Title Summary
Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
Patent number
10,000,561
Abstract
The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
Methods of treating an inflammatory condition or sensitivity to an allergen with anti-IL-33 antibodies
Patent number
10,000,564
Abstract
The present invention provides antibodies that bind to interleukin-33 (IL-33) and methods of using the same. The invention includes antibodies that inhibit or attenuate IL-33-mediated signaling. The antibodies of the invention may function to block the interaction between IL-33 and ST2. Alternatively, certain antibodies of the invention inhibit or attenuate IL-33-mediated signaling without blocking the IL-33/ST2 interaction. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human IL-33 with high affinity. The antibodies of the invention are useful for the treatment of diseases and disorders associated with IL-33 signaling and/or IL-33 cellular expression, such as inflammatory diseases, or allergic diseases.
Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same
Patent number
10,000,566
Abstract
The present invention relates to antibodies that bind CD33. More particularly, the invention relates to anti-CD33 antibodies, fragments and homologues of these antibodies, humanized and resurfaced versions of these antibodies, functional equivalents and improved versions of these antibodies, immunoconjugates and compositions comprising these antibodies, and the uses of same in diagnostic, research and therapeutic applications. The invention also relates to a polynucleotide encoding these antibodies, vectors comprising the polynucleotides, host cells transformed with polynucleotides and methods of producing these antibodies.
Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibody
Patent number
10,000,572
Abstract
The present invention relates to an antibody binding to the transmembrane protein `glycoprotein A repetitions predominant` (GARP) in the presence of TGF-.beta. and uses thereof.
Mixed decyl mercaptans compositions and use thereof as chain transfer agents
Patent number
10,000,590
Abstract
A chain transfer agent composition comprises at least one branched C.sub.10 mercaptan selected from 5-methyl-1-mercapto-nonane, 3-propyl-1-mercapto-heptane, 4-ethyl-1-mercapto-octane, 2-butyl-1-mercapto-hexane, 5-methyl-2-mercapto-nonane, 3-propyl-2-mercapto-heptane, 4-ethyl-2-mercapto-octane, 5-methyl-5-mercapto-nonane, or combinations thereof. The chain transfer agent composition can be a component of an emulsion polymerization mixture and can be used in a process for emulsion polymerization for the production of polymers, for example, via free-radical polymerization.
Catalyst system for polymerization of an olefin
Patent number
10,000,591
Abstract
A process for the preparation of a catalyst system for olefin polymerization, including: A) providing said procatalyst obtainable via a process comprising: i) contacting a compound R.sup.4.sub.zMgX.sup.4.sub.2-z with an alkoxy- or aryloxy-containing silane compound to give a first intermediate reaction product, ii) optionally contacting the solid product obtained in step i) with at least one activating compound selected from an activating electron donor or metal alkoxide compound; iii) contacting the first or second intermediate reaction product, with a halogen-containing Ti-compound and optionally an internal electron donor to obtain the procatalyst; and B) contacting the procatalyst with a co-catalyst and at least diethylaminotriethoxysilane as the external donor. Further disclosed is a catalyst system obtained by the process; a process for preparing a polyolefin by contacting at least one olefin with the catalyst system; a polyolefin obtained thereby; a composition comprising a propylene-ethylene copolymer; a shaped article thereof; and use of the polyolefin.
Supported Salan catalysts
Patent number
10,000,593
Abstract
A catalyst system including the reaction product of a fluorided support, an activator, and at least a first transition metal catalyst compound; methods of making such catalyst systems, polymerization processes using such catalyst systems, and polymers made therefrom.
Metathesized triacylglycerol polyols for use in polyurethane applications and their related properties
Patent number
10,000,601
Abstract
Metathesized triacylglycerol polyols and their related physical and thermal properties are disclosed. Such metathesized triacylglycerol polyols are also used as a component of polyurethane applications, including polyurethane foams.
Method for producing polyamide resin
Patent number
10,000,607
Abstract
A polyamide resin is produced through polycondensation by melt-kneading a polyamide oligomer having a relative viscosity of from 1.1 to 1.3 and a water content of 3% by mass or less in a cylinder (S) of an extruder. The extruder includes open vents (OV1) and (OV2) and vacuum vents (V1) and (V2). The open vent (OV1) is arranged near a supply port (A3), e.g., above the supply port (A3), and a pressure-decreasing element (Y) is arranged on an upstream side with respect to positions of the vacuum vents (V1) and (V2). In addition, the open vent (OV2) is arranged in a preceding area (OA) and is brought into a pressurized state.
Methods of making an elastomer composite reinforced with silica and carbon black and products containing same
Patent number
10,000,613
Abstract
Methods to make a silica and carbon black elastomer composite with a destabilized dispersion that includes silica are described, along with particle reinforced elastomer composites made from the methods. The advantages achieved with the methods are further described.